ETNK1 and atypical chronic myeloid leukemia, BCR-ABL1 negative: The recent discovery of somatic mutations occurring in SETBP1 (22) and ETNK1 (23) in up to a third of aCML cases (22–24) led to the insertion of these mutations in the 2016 WHO revision as supporting criteria for the diagnosis of aCML (1).